|

Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners

RECRUITINGSponsored by Institut Claudius Regaud
Actively Recruiting
SponsorInstitut Claudius Regaud
Started2024-07-30
Est. completion2028-03
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Single-centre prospective pilot study designed to demonstrate the acceptability of onco-sexology management for laryngectomy patients and their partners in order to improve their perception of their intimate life. This is a non-interventional study (category 3 Loi Jardé), which will not result in any change in patient management. All procedures will be carried out in accordance with standard practice. Patients will be followed for 14 months.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

For patients:

1. Patient to be treated for ORL cancer by total (pharyngo)laryngectomy
2. Patient WHO 0-1-2
3. Age greater than or equal to 18 years
4. Patient who has not objected to participation in the study.

For partners (if applicable) :

1. Age greater than or equal to 18 years
2. Subject who has not objected to participation in the study.

Exclusion Criteria:

For patients:

1. Patient with another co-existing malignant disease at the time of inclusion.
2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol.
3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).

For partners (if applicable):

1\. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).

Conditions2

CancerORL Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.